The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings
Open accessAbstract
The dissemination of COVID-19 around the globe has been followed by an increased consumption of antibiotics. This is related to the concern for bacterial superinfection in COVID-19 patients. The identification of bacterial pathogens is challenging in low and middle income countries (LMIC), as there are no readily-available and cost-effective clinical or biological markers that can effectively discriminate between bacterial and viral infections. Fortunately, faced with the threat of COVID-19 spread, there has been a growing awareness of the importance of antimicrobial stewardship programs, as well as infection prevention and control measures that could help reduce the microbial load and hence circulation of pathogens, with a reduction in dissemination of antimicrobial resistance. These measures should be improved particularly in developing countries. Studies need to be conducted to evaluate the worldwide evolution of antimicrobial resistance during the COVID-19 pandemic, because pathogens do not respect borders. This issue takes on even greater importance in developing countries, where data on resistance patterns are scarce, conditions for infectious pathogen transmission are optimal, and treatment resources are suboptimal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1
van Doremalen, N., Bushmaker, T., Morris, D. H., Holbrook, M. G., Gamble, A., Williamson, B. N., Tamin, A., Harcourt, J. L., Thornburg, N. J., Gerber, S. I., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2004973 · Cited by 9,951
Rawson, T. M., Moore, L. S. P., Zhu, N., Ranganathan, N., Skolimowska, K., Gilchrist, M., Satta, G., Cooke, G., & Holmes, A. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa530 · Cited by 1,662
Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/591708 · Cited by 1,625
Co-infections in people with COVID-19: a systematic review and meta-analysis.
Lansbury, L., Lim, B., Baskaran, V., & Lim, W. S. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.046 · Cited by 1,619
Real-time tracking of self-reported symptoms to predict potential COVID-19
Menni, C., Valdes, A. M., Freidin, M. B., Sudre, C. H., Nguyen, L. H., Drew, D. A., Ganesh, S., Varsavsky, T., Cardoso, M. J., El-Sayed Moustafa, J. S., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0916-2 · Cited by 1,517
Tang, W., Cao, Z., Han, M., Wang, Z., Chen, J., Sun, W., Wu, Y., Xiao, W., Liu, S., Chen, E., et al. (2020) · BMJ · doi:10.1136/bmj.m1849 · Cited by 1,135
Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19
Magagnoli, J., Narendran, S., Pereira, F., Cummings, T. H., Hardin, J. W., Sutton, S. S., & Ambati, J. (2020) · Med · doi:10.1016/j.medj.2020.06.001 · Cited by 656
Hughes, S., Troise, O., Donaldson, H., Mughal, N., & Moore, L. S. P. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.06.025 · Cited by 642
Antimicrobial resistance in Africa: a systematic review
Tadesse, B. T., Ashley, E. A., Ongarello, S., Havumaki, J., Wijegoonewardena, M., González, I. J., & Dittrich, S. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2713-1 · Cited by 554
Arshad, S., Kilgore, P., Chaudhry, Z. S., Jacobsen, G., Wang, D. D., Huitsing, K., Brar, I., Alangaden, G. J., Ramesh, M. S., McKinnon, J. E., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.06.099 · Cited by 546
Self-citationAntibiotic stewardship in low- and middle-income countries: the same but different?
Cox, J. A., Vlieghe, E., Mendelson, M., Wertheim, H., Ndegwa, L., Villegas, M. V., Gould, I., & Levy Hara, G. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.07.010 · Cited by 529
Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia.
Hanada, S., Pirzadeh, M., Carver, K. Y., & Deng, J. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02640 · Cited by 495
Clinical management of COVID-19
Varghese, G. M., John, R., Manesh, A., Karthik, R., & Abraham, O. C. (2020) · Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_957_20 · Cited by 467
Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU
Sharifipour, E., Shams, S., Esmkhani, M., Khodadadi, J., Fotouhi-Ardakani, R., Koohpaei, A., Doosti, Z., & EJ Golzari, S. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05374-z · Cited by 417
Saleh, M., Gabriels, J., Chang, D., Soo Kim, B., Mansoor, A., Mahmood, E., Makker, P., Ismail, H., Goldner, B., Willner, J., et al. (2020) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.120.008662 · Cited by 340
Tackling antimicrobial resistance in the COVID-19 pandemic
Getahun, H., Smith, I., Trivedi, K., Paulin, S., & Balkhy, H. H. (2020) · Bulletin of the World Health Organization · doi:10.2471/blt.20.268573 · Cited by 325
Andreani, J., Le Bideau, M., Duflot, I., Jardot, P., Rolland, C., Boxberger, M., Wurtz, N., Rolain, J.-M., Colson, P., La Scola, B., et al. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104228 · Cited by 319
Procalcitonin levels in COVID-19 patients
Hu, R., Han, C., Pei, S., Yin, M., & Chen, X. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106051 · Cited by 296
Antimicrobial use, drug-resistant infections and COVID-19
Rawson, T. M., Ming, D., Ahmad, R., Moore, L. S. P., & Holmes, A. H. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0395-y · Cited by 277
Solidarity” clinical trial for COVID-19 treatments
Mendez, C. M. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 257
Septimus, E. J. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.04.005 · Cited by 239
Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons
Havers, F. P., Hicks, L. A., Chung, J. R., Gaglani, M., Murthy, K., Zimmerman, R. K., Jackson, L. A., Petrie, J. G., McLean, H. Q., Nowalk, M. P., et al. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.0243 · Cited by 231
Roquilly, A., McWilliam, H. E. G., Jacqueline, C., Tian, Z., Cinotti, R., Rimbert, M., Wakim, L., Caminschi, I., Lahoud, M. H., Belz, G. T., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.021 · Cited by 186
Protective measures for COVID-19 for healthcare providers and laboratory personnel
AĞALAR, C., & ÖZTÜRK ENGİN, D. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2004-132 · Cited by 164
Direct interactions with influenza promote bacterial adherence during respiratory infections
Rowe, H. M., Meliopoulos, V. A., Iverson, A., Bomme, P., Schultz-Cherry, S., & Rosch, J. W. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0447-0 · Cited by 161
Alp, E., & Damani, N. (2015) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.6832 · Cited by 151
Using antibiotics responsibly: right drug, right time, right dose, right duration
Dryden, M., Johnson, A. P., Ashiru-Oredope, D. A. I., & Sharland, M. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr370 · Cited by 147
Pneumonia in the developing world: C haracteristic features and approach to management
Aston, S. (2017) · Respirology · doi:10.1111/resp.13112 · Cited by 131
Cardiovascular Toxicities Associated With Hydroxychloroquine and Azithromycin
Nguyen, L. S., Dolladille, C., Drici, M., Fenioux, C., Alexandre, J., Mira, J. P., Moslehi, J. J., Roden, D. M., Funck‐Brentano, C., & Salem, J. (2020) · Circulation · doi:10.1161/circulationaha.120.048238 · Cited by 109
Manohar, P., Loh, B., Athira, S., Nachimuthu, R., Hua, X., Welburn, S. C., & Leptihn, S. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01434 · Cited by 109
Infection control practice in countries with limited resources
Alp, E., Leblebicioğlu, H., Doğanay, M., & Voß, A. (2011) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-10-36 · Cited by 94
COVID-19 Super-spreaders: Definitional Quandaries and Implications
Cave, E. (2020) · Asian Bioethics Review · doi:10.1007/s41649-020-00118-2 · Cited by 77
Tillekeratne, L. G., Bodinayake, C. K., Nagahawatte, A., Vidanagama, D. S., Devasiri, V., Arachchi, W. K., Kurukulasooriya, R. M., Silva, A. D. D., Østbye, T., Reller, M. E., et al. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.15-0269 · Cited by 46
Innate Immune Cell Suppression and the Link With Secondary Lung Bacterial Pneumonia
Morgan, D. J., Casulli, J., Chew, C., Connolly, E., Lui, S., Brand, O. J., Rahman, R., Jagger, C. P., & Hussell, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02943 · Cited by 46
Critical care capacity in Haiti: A nationwide cross-sectional survey
Losonczy, L. I., Barnes, S., Liu, S., Williams, S. R., McCurdy, M. T., Lemos, V., Chandler, J., Colas, L. N., Augustin, M. E., & Papali, A. C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218141 · Cited by 46
Rosenthal, V., Belkebir, S., Zand, F., Afeef, M., Tanzi, V. L., Al-Abdely, H. M., El‐Kholy, A., AlKhawaja, S. A. A., Demiröz, A. P., Sayed, A. F., et al. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.03.012 · Cited by 37
Biagio, A. D., Ameri, M., Sirello, D., Cenderello, G., di Bella, E., Taramasso, L., Giannini, B., Giacomini, M. L., Viscoli, C., Cassola, G., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2199-x · Cited by 31
Phan, H. T., Vo, T. H., Tran, H. T., Huynh, H. T. N., Nguyen, H. T. T., & Nguyen, T. V. (2020) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0669-1 · Cited by 16
Peñafiel, F. S., Poniachik, J. G., Alejandro Canelo, L., & Patiño, O. D. (2018) · Revista médica de Chile · doi:10.4067/s0034-98872018001201371 · Cited by 15
Antimicrobial Resistance: Superbugs and the Imperative to Stop Them
(2021) · Harvard University Press eBooks · doi:10.2307/j.ctv33wwv1d.9 · Cited by 12
Cited by
CAMPR4: a database of natural and synthetic antimicrobial peptides
Gawde, U., Chakraborty, S., Waghu, F. H., Barai, R. S., Khanderkar, A., Indraguru, R., Shirsat, T., & Idicula-Thomas, S. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac933 · Cited by 278
Tomczyk, S., Taylor, A., Brown, A., de Kraker, M. E. A., El-Saed, A., Alshamrani, M., Hendriksen, R. S., Jacob, M., Löfmark, S., Perovic, O., et al. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab300 · Cited by 174
Ivshina, I., Bazhutin, G., & Tyumina, E. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.967127 · Cited by 62
Predisposition of COVID-19 patients to secondary infections: set in stone or subject to change?
Sopirala, M. M. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000736 · Cited by 8
Carrión-Nessi, F. S., Castro, M. P., Freitas-De Nobrega, D. C., Moncada-Ortega, A., Omaña-Ávila, Ó. D., Mendoza-Millán, D. L., Marcano-Rojas, M. V., Trejo, N. J., Virriel, I. V., Chavero, M., et al. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-05253-2 · Cited by 5
Metadata
- Authors
- Lucien, M. A. B., Canarie, M. F., Kilgore, P. E., Jean-Denis, G., Fénélon, N., Pierre, M., Cerpa, M., Joseph, G. A., Maki, G., Zervos, M. J., Dely, P., Boncy, J., Sati, H., Rio, A. D., & Ramon-Pardo, P.
- Venue
- International Journal of Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2021-03
- Volume
- 104
- Pages
- 250-254
- ISSN
- 1201-9712 (ISSN-L)
- OpenAlex
- W3120081043
- Cited by
- 256
- References
- 43
- FWCI
- 26.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.